ONS Insider Trading Activity and SEC Form 4 Filings
ONS insider trading summary
No open-market insider purchases or sales of Oncobiologics, Inc. (ONS) have been reported on SEC Form 4 in the past 12 months.
Latest ONS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 18, 2018 | Lawrence A Kenyon | CEO, Pres, CFO, Treas & Secy | Sell | $9K (10,100 @ $0.87) |
| Jun 25, 2018 | Kenneth Bahrt | Chief Medical Officer | Sell | $7K (7,700 @ $0.85) |
| Jan 4, 2018 | Pankaj Mohan | President & CEO | Sell | $73K (62,569 @ $1.16) |
| Jan 3, 2018 | Pankaj Mohan | President & CEO | Sell | $61K (52,108 @ $1.18) |
| Dec 22, 2017 | Elizabeth A. Yamashita | VP, Regulatory Affairs | Sell | $18K (16,170 @ $1.13) |
| Dec 22, 2017 | Stephen J McAndrew | SVP Bus. Strat. & Dev. | Sell | $18K (15,705 @ $1.13) |
| Dec 22, 2017 | Lawrence A Kenyon | CFO and Secretary | Sell | $30K (26,165 @ $1.13) |
| Dec 22, 2017 | Kenneth Bahrt | Chief Medical Officer | Sell | $30K (26,165 @ $1.13) |
| Dec 19, 2017 | Pankaj Mohan | President & CEO | Sell | $95K (83,608 @ $1.14) |
| Dec 19, 2017 | Elizabeth A. Yamashita | VP, Regulatory Affairs | Sell | $7K (6,151 @ $1.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.